Effect of warm needling plus oral medication on blood lipids in cerebral infarction patients

被引：1

作者：

Xu Z.-J. ^{[1
]}

Qi W. ^{[1
]}

Liu Y. ^{[1
]}

机构：

[1] Rehabilitation Department, Chongqing Three Gorges Central Hospital, Chongqing

来源：

Journal of Acupuncture and Tuina Science | 2017年 / 15卷 / 2期

关键词：

Acupuncture Therapy; Blood Lipid; Cerebral Infarction; Moxibustion Therapy; Rosuvastatin Calcium Tablets; Warm Needling Therapy;

D O I：

10.1007/s11726-017-0986-y

中图分类号：

学科分类号：

摘要：

Objective: To observe the effect of warm needling plus oral administration of rosuvastatin calcium tablets on blood lipids in cerebral infarction patients. Methods: A total of 125 eligible cases were randomly allocated into group A (n=42), group B (n=40) and group C (n=43). Cases in group A received warm needling plus oral administration of rosuvastatin calcium tablets, cases in group B received warm needling, whereas cases in group C received oral administration of rosuvastatin calcium tablets. Results: After treatment, the total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) all dropped obviously in the three groups, with significant differences (all P<0.05), modified Barthel index (BI) scores all significantly rise (all P<0.05), and high-density lipoprotein cholesterol (HDL-C) remained unchanged (all P>0.05). After treatment, the changes of TC, TG and LDL-C in group A were significantly different from those in group B and group C (all P<0.05), while the changes showed no statistical significance between group B and group C (P>0.05). There were no between-group differences in HDL-C among the three groups (all P>0.05); the modified BI scores in group A and group B were significantly higher than that in group C (both P<0.05), while there was no significant difference between group A and group B (P>0.05). After treatment, the total effective rate was significantly higher in group A than that in group B and group C (both P<0.05), there was no significant difference between group B and group C (P>0.05). Conclusion: Warm needling and oral administration of rosuvastatin calcium tablets both can adjust blood lipids effectively in cerebral infarction patients with a similar therapeutic efficacy, while the effect gets better based upon combining both methods; acupuncture-moxibustion plays an important role in the recovery of nerve functions in cerebral infarction patients. © 2017, Shanghai Research Institute of Acupuncture and Meridian and Springer-Verlag Berlin Heidelberg.

引用

页码：115 / 119

页数：4

共 18 条

[1]

Key diagnostic points for cerebrovascular diseases, Zhonghua Shenjingke Zazhi, 29, 6, pp. 379-380, (1996)

[2]

Chinese guidelines on prevention and treatment of dyslipidemia in adults, Zhonghua Xinxueguan Bing Zazhi, 35, 5, pp. 390-409, (2007)

[3]

Guiding Principles for Clinical Study of New Chinese Medicines, (2002)

[4]

Jin H., Zhang H.X., Clinical study on embedding thread at Fenglong point in the treatment of hyperlipemia, Zhenjiu Linchuang Zazhi, 28, 4, pp. 8-9, (2012)

[5]

Ma M.Y., Jiang J.F., Zhou X.Y., Ji M.Y., Wang L.L., Effect of moxibustion on blood fat and glucose in hyperlipemia patients, Shanghai Zhenjiu Zazhi, 31, 8, pp. 535-536, (2012)

[6]

Le W., Zhang H.X., Wang Q., Huang G.F., Zhou L., Qin P.F., Modulatory effect of electroacupuncture at Fenglong (ST 40) on blood lipid and inflammatory factors in livers of rat hyperlipidemia model, Zhongguo Kangfu, 30, 1, pp. 7-9, (2015)

[7]

Guo A.S., Li A.H., Chen X., Zhu Z.J., Sun L., Clinical observation on needle-embedding method on Fenglong (ST 40) and Zusanli (ST 36) for lipid metabolism and homocysteine level on acute cerebral infarction patients, Zhongguo Laonianxue Zazhi, 35, 12, pp. 3310-3312, (2015)

[8]

He J.F., Yan J., Huang H.Y., Li J.S., Wang C., Li L.D., Qu Y.T., Effect of puncturing acupoint from the Stomach Meridian on blood lipids and hypothalamic insulin receptor substrate-1 and serine phosphorylation activity in diet induced obese rats, Zhongyi Yanjiu, 26, 2, pp. 63-65, (2013)

[9]

Jones P.H., Davidson M.H., Stein E.A., Bays H.E., McKenney J.M., Miller E., Cain V.A., Blasetto J.W., Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial), Am J Cardiol, 92, 2, pp. 152-160, (2003)

[10]

Nicholls S.J., Uno K., Kataoka Y., Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk, Expert Rev Cardiovasc Ther, 9, 11, pp. 1383-1390, (2011)

← 1 2 →